This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Ion channels 3D structures
From Proteopedia
(Difference between revisions)
| (13 intermediate revisions not shown.) | |||
| Line 164: | Line 164: | ||
**[[6lyp]], [[6vxm]], [[6vxn]], [[6vxp]] – AtMsc-like (mutant) – Cryo EM<br /> | **[[6lyp]], [[6vxm]], [[6vxn]], [[6vxp]] – AtMsc-like (mutant) – Cryo EM<br /> | ||
| - | * Chloride channel or H(+)/Cl(-) exchange transporter ClcA or human proton-activated chloride channel PAC | + | * Chloride channel or H(+)/Cl(-) exchange transporter ClcA or human proton-activated chloride channel PAC or CLIC |
**[[1rk4]], [[3swl]] - hClCh protein 1<br /> | **[[1rk4]], [[3swl]] - hClCh protein 1<br /> | ||
| Line 226: | Line 226: | ||
* Ligand-gated ion channel | * Ligand-gated ion channel | ||
| - | **[[ | + | **[[5osa]], [[5osb]] – mGLIC + GABAAR <br /> |
| - | **[[2yks]], [[4twh]] - EchELIC (mutant)<br /> | + | **[[5osc]] – mGLIC + GABAAR + drug<br /> |
| + | **[[2vl0]], [[3rqu]], [[2yn6]] – EchELIC –'' Erwinia chrysanthemi''<br /> | ||
| + | **[[2yks]], [[3uq4]], [[3uq5]], [[3uq7]], [[4twh]], [[5hej]], [[5heo]], [[5heu]], [[5hew]] – EchELIC (mutant)<br /> | ||
| + | **[[6v03]], [[6v0b]], [[8d63]], [[8d64]], [[8d65]] - EchELIC – Cryo EM<br /> | ||
| + | **[[8d66]], [[8d67]], [[8vuw]] – EchELIC3 (mutant) – Cryo EM<br /> | ||
**[[3rqw]] - EchELIC + acetylcholine<br /> | **[[3rqw]] - EchELIC + acetylcholine<br /> | ||
| + | **[[5sxu]] - EchELIC + bromoethanol<br /> | ||
**[[4twd]], [[4twf]] - EchELIC (mutant) + memantine derivative<br /> | **[[4twd]], [[4twf]] - EchELIC (mutant) + memantine derivative<br /> | ||
**[[3zkr]] - EchELIC + anesthetic<br /> | **[[3zkr]] - EchELIC + anesthetic<br /> | ||
| - | + | **[[2yoe]] - EchELIC + drug + GABA<br /> | |
| - | **[[2yoe]] - EchELIC + | + | **[[4a97]], [[4a98]], [[5lid]], [[5lg3]] – EchELIC + drug<br /> |
| - | **[[5lid]] – EchELIC + | + | |
**[[5sxv]] – EchELIC + inhibitor <br /> | **[[5sxv]] – EchELIC + inhibitor <br /> | ||
| + | **[[4yeu]] – EchELIC + GLIC <br /> | ||
| + | **[[6hk0]] – DcELIC (mutant) – Dickeya chrysanthemi<br /> | ||
| + | **[[6hjx]], [[6hjy]], [[6ssi]], [[6ssp]] – DcELIC + nanobody <br /> | ||
| + | **[[6fl9]], [[6fli]], [[6fvq]], [[6fvr]], [[6fvs]] - ELIC – vent tica<br /> | ||
| + | **[[3eam]], [[3ehz]], [[4hfi]], [[4il4]], [[4ilc]], [[4npp]], [[4npq]], [[4qh1]], [[4qh5]], [[4qh4]], [[6f7a]], [[6f16]], [[4zzc]], [[6hzw]] – GvGLIC - Gloeobacter violaceus<br /> | ||
| + | **[[6zgd]], [[6zgj]], [[6zgk]] – GvGLIC – Cryo EM<br /> | ||
**[[6hk0]] – DcELIC (mutant) – ''Dickeya chrysanthemi''<br /> | **[[6hk0]] – DcELIC (mutant) – ''Dickeya chrysanthemi''<br /> | ||
**[[6hjx]], [[6hjy]], [[6ssi]], [[6ssp]] – DcELIC + nanobody <br /> | **[[6hjx]], [[6hjy]], [[6ssi]], [[6ssp]] – DcELIC + nanobody <br /> | ||
| Line 249: | Line 259: | ||
**[[5l47]], [[5l4e]], [[5l4h]] - GvGLIC + barbiturate<br /> | **[[5l47]], [[5l4e]], [[5l4h]] - GvGLIC + barbiturate<br /> | ||
**[[6hj3]], [[6hjb]], [[6hji]], [[6hja]], [[6hjz]], [[6hpp]] - GvGLIC + carboxylate<br /> | **[[6hj3]], [[6hjb]], [[6hji]], [[6hja]], [[6hjz]], [[6hpp]] - GvGLIC + carboxylate<br /> | ||
| - | **[[ | + | **[[6v4a]], [[6v4s]], [[7q3g]] - DeELIC – ''Desulfofustis''<br /> |
| + | **[[7q3h]] – DeELIC – Cryo EM<br /> | ||
* Cyclic Nucleotide-Gated channel | * Cyclic Nucleotide-Gated channel | ||
| Line 256: | Line 267: | ||
**[[7lft]] – hCNGA1 + cGMP – Cryo EM<br /> | **[[7lft]] – hCNGA1 + cGMP – Cryo EM<br /> | ||
**[[7lfw]], [[7lfx]], [[7lfy]] – hCNGA1 (mutant) + cGMP – Cryo EM<br /> | **[[7lfw]], [[7lfx]], [[7lfy]] – hCNGA1 (mutant) + cGMP – Cryo EM<br /> | ||
| + | **[[7rh9]], [[7rhl]] – hCNGA1 + CNGB1 – Cryo EM<br /> | ||
| + | **[[7rhg]], [[7rhh]], [[7rhi]], [[7rhj]], [[7rhk]] – hCNGA1 + CNGB1 + cGMP – Cryo EM<br /> | ||
| + | **[[8bx7]] – bCNGA1 + CNGB1 + cGMP – Cryo EM<br /> | ||
| + | **[[7rhs]] – hCNGA3 + CNGB3 – Cryo EM<br /> | ||
**[[3swf]] - bCNGC CLZ domain <br /> | **[[3swf]] - bCNGC CLZ domain <br /> | ||
**[[2zd9]], [[3beh]] - MlCNGC - ''Mesorhizobium loti''<br /> | **[[2zd9]], [[3beh]] - MlCNGC - ''Mesorhizobium loti''<br /> | ||
| Line 296: | Line 311: | ||
**[[7rnn]] – hASC + nanobody – Cryo EM<br /> | **[[7rnn]] – hASC + nanobody – Cryo EM<br /> | ||
**[[3ij4]], [[2qts]], [[3s3w]], [[4nyk]], [[3ij4]], [[6ave]], [[5wku]], [[5wkv]], [[5wky]], [[5wkx]], [[6cmc]] – cASC – chicken<br /> | **[[3ij4]], [[2qts]], [[3s3w]], [[4nyk]], [[3ij4]], [[6ave]], [[5wku]], [[5wkv]], [[5wky]], [[5wkx]], [[6cmc]] – cASC – chicken<br /> | ||
| + | **[[7lie]] – cASC thumb domain 291-367<br /> | ||
**[[6vtk]], [[6vtl]] – cASC – Cryo EM<br /> | **[[6vtk]], [[6vtl]] – cASC – Cryo EM<br /> | ||
**[[3s3x]], [[4fz0]], [[4fz1]] – cASC + psalmotoxin<br /> | **[[3s3x]], [[4fz0]], [[4fz1]] – cASC + psalmotoxin<br /> | ||
| Line 301: | Line 317: | ||
**[[6x9h]] – cASC + modulator<br /> | **[[6x9h]] – cASC + modulator<br /> | ||
| - | * ATP-Gated P2X channel (AGC) or purinoceptor | + | * ATP-Gated P2X channel (AGC) or P2X purinoceptor |
| - | **[[ | + | **[[5svj]], [[5svs]], [[5svt]] – hAGC P2X3 <br /> |
**[[5yve]] – hAGC P2X3 + modulator<br /> | **[[5yve]] – hAGC P2X3 + modulator<br /> | ||
**[[5svq]], [[5svr]] – hAGC P2X3 + antagonist<br /> | **[[5svq]], [[5svr]] – hAGC P2X3 + antagonist<br /> | ||
**[[5svm]], [[5svp]] – hAGC P2X3 + agonist<br /> | **[[5svm]], [[5svp]] – hAGC P2X3 + agonist<br /> | ||
**[[5svk]], [[5svl]], [[6ah4]], [[6ah5]] – hAGC P2X3 + ATP<br /> | **[[5svk]], [[5svl]], [[6ah4]], [[6ah5]] – hAGC P2X3 + ATP<br /> | ||
| + | **[[5u1l]] – paAGC P2X - panda<br /> | ||
| + | **[[5u1u]], [[5u1v]], [[5u1w]], [[5u1x]], [[5u1y]] – paAGC P2X + antagonist <br /> | ||
| + | **[[5u2h]] – paAGC P2X + antagonist + ATP <br /> | ||
| + | **[[6u9v]] – raAGC P2X7 – Cryo EM<br /> | ||
| + | **[[6u9w]] – raAGC P2X7 + ATP – Cryo EM<br /> | ||
| + | **[[2rup]] – raAGC P2X4 head domain 111-167 – NMR<br /> | ||
**[[5xw6]] – cAGC P2X7 + antagonist<br /> | **[[5xw6]] – cAGC P2X7 + antagonist<br /> | ||
**[[3h9v]], [[3i5d]] – zeAGC P2X4<br /> | **[[3h9v]], [[3i5d]] – zeAGC P2X4<br /> | ||
**[[4dw0]] – zeAGC P2X4 (mutant)<br /> | **[[4dw0]] – zeAGC P2X4 (mutant)<br /> | ||
**[[4dw1]] – zeAGC P2X4 + ATP<br /> | **[[4dw1]] – zeAGC P2X4 + ATP<br /> | ||
| + | **[[5wzy]] – zeAGC P2X4 + CTP<br /> | ||
* Proton channel or matrix protein 2 | * Proton channel or matrix protein 2 | ||
| Line 321: | Line 344: | ||
**[[5c02]], [[4rwc]], [[4rwb]], [[2kih]], [[6mjh]] - IVproton channel transmembrane domain (mutant)<br /> | **[[5c02]], [[4rwc]], [[4rwb]], [[2kih]], [[6mjh]] - IVproton channel transmembrane domain (mutant)<br /> | ||
**[[2n70]] - IVproton channel transmembrane domain (mutant) - NMR<br /> | **[[2n70]] - IVproton channel transmembrane domain (mutant) - NMR<br /> | ||
| - | **[[6bkk]], [[6bkl]], [[6bmz]], [[6boc]] - IVproton channel transmembrane domain + drug<br /> | + | **[[6bkk]], [[6bkl]], [[6bmz]], [[6boc]], [[6us8]], [[6us9]] - IVproton channel transmembrane domain + drug<br /> |
| - | **[[2kqt]] - IVproton channel transmembrane domain + drug - NMR<br /> | + | **[[2h95]], [[2kqt]] - IVproton channel transmembrane domain + drug - NMR<br /> |
**[[2ly0]] - IVproton channel transmembrane domain (mutant) + drug - NMR<br /> | **[[2ly0]] - IVproton channel transmembrane domain (mutant) + drug - NMR<br /> | ||
**[[2rlf]] - IVproton channel + inhibitor - NMR<br /> | **[[2rlf]] - IVproton channel + inhibitor - NMR<br /> | ||
**[[3c9j]], [[6oug]] - IVproton channel transmembrane domain + inhibitor<br /> | **[[3c9j]], [[6oug]] - IVproton channel transmembrane domain + inhibitor<br /> | ||
**[[6nv1]] - IVproton channel transmembrane domain (mutant) + inhibitor<br /> | **[[6nv1]] - IVproton channel transmembrane domain (mutant) + inhibitor<br /> | ||
| + | **[[8bdz]], [[8ber]] - proton channel M2 – Hepatitis virus – Cryo EM<br /> | ||
* Voltage-gated hydrogen channel (VGHC) | * Voltage-gated hydrogen channel (VGHC) | ||
| Line 340: | Line 364: | ||
*''TRPV1 or capsaicin receptor'' | *''TRPV1 or capsaicin receptor'' | ||
| + | **[[7lp9]], [[7lpa]], [[7lpc]], [[7lpd]], [[8gf8]], [[8gf9]], [[8gfa]] – hTRPV1 – Cryo EM<br /> | ||
| + | **[[6l93]] – hTRPV1 ankyrin repeat domain 101-365<br /> | ||
| + | **[[2nyj]] – hTRPV1 ankyrin repeat domain + ATP<br /> | ||
**[[7lqy]], [[7lqz]] – sTRPV1 – squirrel - Cryo EM<br /> | **[[7lqy]], [[7lqz]] – sTRPV1 – squirrel - Cryo EM<br /> | ||
**[[7lr0]] – sTRPV1 + capsaicin - Cryo EM<br /> | **[[7lr0]] – sTRPV1 + capsaicin - Cryo EM<br /> | ||
| - | **[[6l93]] – hTRPV1 ankyrin repeat domain 101-365<br /> | ||
**[[3j5p]], [[3j5r]], [[3j9j]], [[5irz]] – rTRPV1 – Cryo EM<br /> | **[[3j5p]], [[3j5r]], [[3j9j]], [[5irz]] – rTRPV1 – Cryo EM<br /> | ||
**[[5is0]] – rTRPV1+ capsaicin derivative – Cryo EM<br /> | **[[5is0]] – rTRPV1+ capsaicin derivative – Cryo EM<br /> | ||
| Line 348: | Line 374: | ||
**[[3j5q]] – rTRPV1+ toxin – Cryo EM<br /> | **[[3j5q]] – rTRPV1+ toxin – Cryo EM<br /> | ||
**[[2pnn]] – rTRPV1 ankyrin repeat domain <br /> | **[[2pnn]] – rTRPV1 ankyrin repeat domain <br /> | ||
| - | **[[ | + | **[[7l2h]], [[7l2i]], [[7l2j]], [[7l2k]], [[7l2l]], [[7l2m]], [[7l2n]], [[7l2o]], [[7l2p]], [[7l2r]], [[7l2s]], [[7l2t]], [[7l2u]], [[7l2v]], [[7l2w]], [[7l2x]], [[7lpb]], [[7lpe]], [[7mz5]], [[7mz6]], [[7mz7]], [[7mz9]], [[7mza]], [[7mzb]], [[7mzc]], [[7mzd]], [[7mze]], [[7rqu]], [[7rqv]], [[7rqw]], [[7rqx]], [[7rqy]], [[7rqz]] – raTRPV1 + drug – Cryo EM<br /> |
*''TRPV2'' | *''TRPV2'' | ||
| Line 356: | Line 382: | ||
**[[2eta]], [[2etb]], [[2etc]] – rTRPV2 ankyrin repeat domain - rat<br /> | **[[2eta]], [[2etb]], [[2etc]] – rTRPV2 ankyrin repeat domain - rat<br /> | ||
**[[6bo4]], [[6bo5]], [[6u84]], [[6u86]] – rTRPV2 – Cryo EM<br /> | **[[6bo4]], [[6bo5]], [[6u84]], [[6u86]] – rTRPV2 – Cryo EM<br /> | ||
| + | **[[6wkn]], [[7n0m]], [[7n0n]], [[7t37]], [[7t38]], [[7zjh]], [[8slx]], [[8sly]] – raTRPV2 + cannabidiol – Cryo EM<br /> | ||
**[[6u88]], [[6u8a]] – rTRPV2 + cannabidiol – Cryo EM<br /> | **[[6u88]], [[6u8a]] – rTRPV2 + cannabidiol – Cryo EM<br /> | ||
**[[6bwm]] – raTRPV2 – rabbit<br /> | **[[6bwm]] – raTRPV2 – rabbit<br /> | ||
| Line 361: | Line 388: | ||
**[[6bwj]] – raTRPV2 (mutant) + resiniferatoxin<br /> | **[[6bwj]] – raTRPV2 (mutant) + resiniferatoxin<br /> | ||
**[[6b5v]] – raTRPV2 + inhibitor – Cryo EM<br /> | **[[6b5v]] – raTRPV2 + inhibitor – Cryo EM<br /> | ||
| + | **[[7xeu]] – mTRPV2 – Cryo EM<br /> | ||
| + | **[[7xer]], [[7xew]] – mTRPV2 (mutant) – Cryo EM<br /> | ||
| + | **[[7xem]] – mTRPV2 + cholesterol – Cryo EM<br /> | ||
| + | **[[7xeo]], [[7xev]], [[7yep]] – mTRPV2 + ligand – Cryo EM<br /> | ||
*''TRPV3'' | *''TRPV3'' | ||
| Line 367: | Line 398: | ||
**[[6ot2]], [[6uw6]], [[6uw8]], [[6uw9]] – hTRPV3 (mutant) – Cryo EM<br /> | **[[6ot2]], [[6uw6]], [[6uw8]], [[6uw9]] – hTRPV3 (mutant) – Cryo EM<br /> | ||
**[[6ot5]] – hTRPV3 (mutant) + inhibitor – Cryo EM<br /> | **[[6ot5]] – hTRPV3 (mutant) + inhibitor – Cryo EM<br /> | ||
| - | **[[6dvw]], [[6dvy]], [[6lgp]], [[6pvl]], [[6pvm]] – mTRPV3 – Cryo EM<br /> | + | **[[7xj0]] – hTRPV3 + drug – Cryo EM<br /> |
| + | **[[6dvw]], [[6dvy]], [[6lgp]], [[6pvl]], [[6pvm]], [[7mik]] – mTRPV3 – Cryo EM<br /> | ||
| + | **[[7mij]], [[7mik]], [[7mil]], [[7mim]], [[7min]], [[7mio]], [[7ras]], [[7rau]], [[7ugg]] – mTRPV3 + drug – Cryo EM<br /> | ||
**[[6dvz]], [[6pvn]], [[6pvp]], [[6pvo]], [[6pvq]] – mTRPV3 (mutant) – Cryo EM<br /> | **[[6dvz]], [[6pvn]], [[6pvp]], [[6pvo]], [[6pvq]] – mTRPV3 (mutant) – Cryo EM<br /> | ||
**[[4n5q]] – mTRPV3 ankyrin repeat domain 118-367<br /> | **[[4n5q]] – mTRPV3 ankyrin repeat domain 118-367<br /> | ||
| Line 373: | Line 406: | ||
*''TRPV4'' | *''TRPV4'' | ||
| + | **[[7aa5]] – hTRPV4 + agonist – Cryo EM<br /> | ||
| + | **[[4dx1]], [[4dx2]] – hTRPV4 ankyrin repeat domain 149-397<br /> | ||
**[[6c8f]], [[6c8g]], [[6c8h]] – fTRPV4 (mutant) – frog<br /> | **[[6c8f]], [[6c8g]], [[6c8h]] – fTRPV4 (mutant) – frog<br /> | ||
**[[6bbj]] – fTRPV4 – Cryo EM<br /> | **[[6bbj]] – fTRPV4 – Cryo EM<br /> | ||
| Line 381: | Line 416: | ||
**[[5oeo]] – hTRPV5 655-725 + calmodulin – NMR<br /> | **[[5oeo]] – hTRPV5 655-725 + calmodulin – NMR<br /> | ||
| - | **[[6dmr]], [[6dmu]], [[6o1n]], [[6o1p]], [[6pbe]], [[6pbf]] – | + | **[[6dmr]], [[6dmu]], [[6o1n]], [[6o1p]], [[6pbe]], [[6pbf]], [[7t6j]], [[7t6k]], [[7t6l]], [[7t6m]], [[7t6n]], [[7t6o]] – rTRPV5 – Cryo EM<br /> |
| - | **[[6o1u]] – | + | **[[6o1u]], [[7t6p]], [[7t6q]], [[7t6r]] – rTRPV5 (mutant) – Cryo EM<br /> |
**[[6dmw]], [[6o20]] – raTRPV5 + calmodulin – Cryo EM<br /> | **[[6dmw]], [[6o20]] – raTRPV5 + calmodulin – Cryo EM<br /> | ||
*''TRPV6'' | *''TRPV6'' | ||
| - | **[[6bo8]], [[6bo9]] – hTRPV6 – Cryo EM<br /> | + | **[[6bo8]], [[6bo9]], [[7k4a]], [[8fob]] – hTRPV6 – Cryo EM<br /> |
**[[6boa]], [[6d7s]], [[6d7t]] – hTRPV6 (mutant) – Cryo EM<br /> | **[[6boa]], [[6d7s]], [[6d7t]] – hTRPV6 (mutant) – Cryo EM<br /> | ||
| + | **[[7k4b]], [[7k4c]], [[7k4d]], [[7k4e]], [[7k4f]], [[7s8c]], [[8foa]] – hTRPV6 + inhibitor – Cryo EM<br /> | ||
| + | **[[7s88]], [[7s89]], [[7s8b]] – hTRPV6 + blocker – Cryo EM<br /> | ||
**[[5iwk]], [[5iwp]], [[5iwr]], [[5iwt]], [[5wo6]], [[5wo7]], [[5wo8]], [[5wo9]], [[5woa]], [[6d7o]], [[6d7v]] – rTRPV6<br /> | **[[5iwk]], [[5iwp]], [[5iwr]], [[5iwt]], [[5wo6]], [[5wo7]], [[5wo8]], [[5wo9]], [[5woa]], [[6d7o]], [[6d7v]] – rTRPV6<br /> | ||
**[[6d7p]], [[6d7q]], [[6d7x]] – rTRPV6 (mutant) <br /> | **[[6d7p]], [[6d7q]], [[6d7x]] – rTRPV6 (mutant) <br /> | ||
| Line 394: | Line 431: | ||
**[[6e2f]], [[6e2g]] – rTRPV6 + calmodulin – Cryo EM<br /> | **[[6e2f]], [[6e2g]] – rTRPV6 + calmodulin – Cryo EM<br /> | ||
**[[2rfa]] – mTRPV6 ankyrin repeat domain 44-265<br /> | **[[2rfa]] – mTRPV6 ankyrin repeat domain 44-265<br /> | ||
| + | **[[7d2k]] – raTRPV6 + inhibitor – Cryo EM<br /> | ||
*Glycerol facilitator | *Glycerol facilitator | ||
Current revision
3D structures of ion channels
Updated on 05-May-2024
